INmune Bio IncNASDAQ:INMB
- LAST PRICE6.7100
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots6.2500/ 2
- Ask / Lots6.8300/ 1
- Open / Previous Close0.0000 / 6.7100
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | INMB |
|---|---|---|
| 09:32 ET | 1043 | 6.5 |
| 09:34 ET | 100 | 6.6495 |
| 09:36 ET | 5000 | 6.5 |
| 09:52 ET | 100 | 6.58 |
| 09:57 ET | 1400 | 6.6003 |
| 10:03 ET | 1100 | 6.6 |
| 10:10 ET | 600 | 6.63 |
| 10:17 ET | 1000 | 6.7363 |
| 10:21 ET | 200 | 6.72 |
| 10:28 ET | 300 | 6.695 |
| 10:30 ET | 100 | 6.7 |
| 10:32 ET | 1400 | 6.75 |
| 10:51 ET | 5743 | 6.8 |
| 10:55 ET | 200 | 6.75 |
| 11:00 ET | 600 | 6.61 |
| 11:13 ET | 208 | 6.695 |
| 11:26 ET | 400 | 6.6 |
| 11:29 ET | 100 | 6.7006 |
| 11:47 ET | 500 | 6.705 |
| 11:51 ET | 150 | 6.72 |
| 12:21 ET | 250 | 6.655 |
| 12:30 ET | 500 | 6.7481 |
| 01:01 ET | 300 | 6.75 |
| 01:12 ET | 200 | 6.75 |
| 01:26 ET | 100 | 6.67 |
| 01:37 ET | 200 | 6.71 |
| 01:42 ET | 1270 | 6.73 |
| 02:33 ET | 800 | 6.76 |
| 02:44 ET | 1000 | 6.7116 |
| 03:05 ET | 700 | 6.7646 |
| 03:32 ET | 975 | 6.8 |
| 03:34 ET | 300 | 6.7235 |
| 03:52 ET | 1000 | 6.6529 |
| 03:59 ET | 883 | 6.71 |
Mar 2, 2023
BRIEF-Inmune Bio, Inc. Announces 2022 Results And Provides Business Update, from 5:07PM ET on Thursday Mar 02, 2023 by Thomson Reuters
5:07PM ET on Thursday Mar 02, 2023 by Thomson ReutersINmune Bio, Inc. Announces 2022 Results and Provides Business Update, from 4:05PM ET on Thursday Mar 02, 2023 by GlobeNewswire
4:05PM ET on Thursday Mar 02, 2023 by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
INmune Bio Inc | 120.4M | -4.4x | --- |
Gossamer Bio Inc | 119.7M | -0.5x | --- |
Bioatla Inc | 118.5M | -0.9x | --- |
Galectin Therapeutics Inc | 115.9M | -3.3x | --- |
Genenta Science SPA | 106.0M | -27.4x | --- |
Shattuck Labs Inc | 127.3M | -1.2x | --- |
Company Information
INmune Bio, Inc. is a clinical-stage biotechnology pharmaceutical company. The Company is focused on developing and commercializing its product candidates to treat diseases where the innate immune system is not functioning normally and contributing to the patient’s disease. Its drug candidates include INKmune, INB03, and XPro1595 (XPro). It has two product platforms. The DN-TNF product platform utilizes dominant-negative technology to selectively neutralize soluble tumor necrosis factor alpha (TNF), a driver of innate immune dysfunction and mechanistic target of many diseases. DN-TNF is being developed for Alzheimer’s and treatment resistant depression (XPro) and cancer (INB03). The Natural Killer (NK) Cell Priming Platform includes INKmune for priming the patient’s NK cells to eliminate minimal residual disease in patients with cancer. Its product platforms utilize a precision medicine approach for the treatment of hematologic malignancies, solid tumors, and chronic inflammation.
Contact Information
- Headquarters
- 225 Ne Mizner Blvd, Suite 640BOCA RATON, FL, United States 33432
- Phone
- 858-964-3720
- Fax
- ---
Executives
- President, Chief Executive Officer, Director
- Raymond Tesi
- Chief Financial Officer
- David Moss
- Chief Scientific Officer
- Mark Lowdell
- Independent Director
- Marcia Allen
- Independent Director
- Edgardo Baracchini
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $120.4M |
|---|---|
Revenue (TTM) | $374.0K |
Shares Outstanding | 17.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.03 |
EPS | $-1.52 |
Book Value | $3.35 |
P/E Ratio | -4.4x |
Price/Sales (TTM) | 322.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -6,938.77% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
